Tandem Diabetes Care | Себестоимость



Cost Of Sales Изменить Дата
Abbott USD 4.94B 246M 2024-12
Align Technology USD 298.28M 2.18M 2024-12
AtriCure USD 31.66M 2.54M 2024-12
Baxter International USD 1.74B 73M 2024-12
Becton, Dickinson and Co. USD 2.93B 21M 2024-12
Boston Scientific USD 1.46B 158M 2024-12
Cooper Companies USD 304.5M 36.2M 2025-01
Dexcom USD 404.2M 3.8M 2024-12
Edwards Lifesciences USD 292.2M 29.3M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Globus Medical USD 263.44M 7.08M 2024-12
ICU Medical USD 402.55M 18.27M 2024-12
Insulet USD 166.6M 200K 2024-12
Integra LifeSciences USD 176.8M 14.01M 2024-12
Intuitive Surgical USD 771.3M 107.1M 2024-12
J&J USD 7.11B 151M 2024-12
Masimo USD 356M 114.6M 2024-12
Medtronic USD 2.78B 160M 2025-01
Merit Medical Systems USD 182.18M 135K 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Stryker USD 2.24B 261M 2024-12
Tandem Diabetes Care USD 125.19M 5.88M 2024-12
Teleflex USD 355.49M 21.29M 2024-12
Zimmer Biomet Holdings USD 586.7M 48.1M 2024-12



Tandem Diabetes Care Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Apr 2025.